Lack of ritonavir antifungal effect in vitro.
作者信息
Diz P, Ocampo A, Iglesias I, Otero I
出版信息
Antimicrob Agents Chemother. 1999 Apr;43(4):997. doi: 10.1128/AAC.43.4.997.
Abstract
摘要
相似文献
1
Lack of ritonavir antifungal effect in vitro.利托那韦在体外缺乏抗真菌作用。
Antimicrob Agents Chemother. 1999 Apr;43(4):997. doi: 10.1128/AAC.43.4.997.
2
In vitro and in vivo anticandidal activity of human immunodeficiency virus protease inhibitors.人类免疫缺陷病毒蛋白酶抑制剂的体外和体内抗念珠菌活性。
J Infect Dis. 1999 Aug;180(2):448-53. doi: 10.1086/314871.
3
Ritonavir (Norvir).
Res Initiat Treat Action. 2000 Mar;6(1):26-7.
4
Dissimilar attenuation of Candida albicans virulence properties by human immunodeficiency virus type 1 protease inhibitors.人类免疫缺陷病毒1型蛋白酶抑制剂对白色念珠菌毒力特性的不同衰减作用。
Immunobiology. 1999 Sep;201(1):133-44. doi: 10.1016/S0171-2985(99)80052-7.
5
Drug-drug interaction between itraconazole and the antiretroviral drug lopinavir/ritonavir in an HIV-1-infected patient with disseminated histoplasmosis.一名播散性组织胞浆菌病的HIV-1感染患者中伊曲康唑与抗逆转录病毒药物洛匹那韦/利托那韦之间的药物相互作用。
Clin Infect Dis. 2004 Apr 15;38(8):e73-5. doi: 10.1086/382675. Epub 2004 Apr 1.
6
Clearance of a fluconazole-resistant Candida albicans strain after switching antifungal therapy and initiation of triple therapy for HIV infection.在更换抗真菌治疗并开始针对HIV感染的三联疗法后，清除氟康唑耐药白色念珠菌菌株。
Clin Microbiol Infect. 2000 Apr;6(4):220-3. doi: 10.1046/j.1469-0691.2000.00041-1.x.
7
Effect of ritonavir and saquinavir on Candida albicans growth rate and in vitro activity of aspartyl proteinases.利托那韦和沙奎那韦对白色念珠菌生长速率及天冬氨酸蛋白酶体外活性的影响。
Med Mycol. 2003 Apr;41(2):167-70. doi: 10.1080/mmy.41.2.167.170.
8
HIV protease inhibitors attenuate adherence of Candida albicans to epithelial cells in vitro.HIV蛋白酶抑制剂在体外可减弱白色念珠菌对上皮细胞的黏附。
FEMS Immunol Med Microbiol. 2001 Jul;31(1):65-71. doi: 10.1111/j.1574-695X.2001.tb01588.x.
9
Oropharyngeal candidiasis in HIV-infected patients under treatment with protease inhibitors.接受蛋白酶抑制剂治疗的HIV感染患者的口咽念珠菌病
Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2004 Sep;98(3):301-10. doi: 10.1016/S1079210404003543.
10
Emergence of protease resistance during simplification therapy with lopinavir/ritonavir alone.
HIV Clin Trials. 2007 Mar-Apr;8(2):105-6. doi: 10.1310/hct0802-105.
引用本文的文献
1
Candida albicans secreted aspartyl proteinases in virulence and pathogenesis.白色念珠菌分泌天冬氨酸蛋白酶在毒力和发病机制中的作用。
Microbiol Mol Biol Rev. 2003 Sep;67(3):400-28, table of contents. doi: 10.1128/MMBR.67.3.400-428.2003.
本文引用的文献
1
Personal opinion: Can antifungal sensitivity tests predict clinical treatment outcomes?
Rev Iberoam Micol. 1997 Sep;14(3):83-4.
2
Risk factors and physiopathology of candidiasis.念珠菌病的危险因素及病理生理学
Rev Iberoam Micol. 1997 Mar;14(1):6-13.
3
4
Human immunodeficiency virus type 1 gp160 and gp41 binding to Candida albicans selectively enhances candidal virulence in vitro.1型人类免疫缺陷病毒糖蛋白160和糖蛋白41与白色念珠菌的结合在体外选择性增强念珠菌的毒力。
J Infect Dis. 1998 Apr;177(4):1057-63. doi: 10.1086/515231.
5
Reduction in oropharyngeal candidiasis following introduction of protease inhibitors.引入蛋白酶抑制剂后口咽念珠菌病减少。
AIDS. 1998 Mar 5;12(4):447-8.
6
Sentinels and signposts: the epidemiology and significance of the oral manifestations of HIV disease.哨兵与路标：HIV 疾病口腔表现的流行病学及意义
Oral Dis. 1997 May;3 Suppl 1:S13-7. doi: 10.1111/j.1601-0825.1997.tb00344.x.
7
The role of Candida albicans secreted aspartic proteinase in the development of candidoses.白色念珠菌分泌天冬氨酸蛋白酶在念珠菌病发展中的作用。
J Mol Med (Berl). 1996 Mar;74(3):135-42. doi: 10.1007/BF01575445.
8
Resolution of refractory AIDS-related mucosal candidiasis after initiation of didanosine plus saquinavir.
N Engl J Med. 1996 Jun 20;334(25):1674-5. doi: 10.1056/NEJM199606203342516.
9
Elevated aspartic proteinase secretion and experimental pathogenicity of Candida albicans isolates from oral cavities of subjects infected with human immunodeficiency virus.从感染人类免疫缺陷病毒的受试者口腔中分离出的白色念珠菌，其天冬氨酸蛋白酶分泌增加及实验致病性
Infect Immun. 1996 Feb;64(2):466-71. doi: 10.1128/iai.64.2.466-471.1996.
Zotero 插件